KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to 0.82.

  • Acadia Pharmaceuticals' Asset Utilization Ratio fell 1664.39% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year decrease of 1664.39%. This contributed to the annual value of 0.99 for FY2024, which is 899.47% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Asset Utilization Ratio of 0.82 as of Q3 2025, which was down 1664.39% from 0.86 recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 1.05 for Q4 2023, and its period low was 0.6 during Q1 2021.
  • For the 5-year period, Acadia Pharmaceuticals' Asset Utilization Ratio averaged around 0.84, with its median value being 0.85 (2023).
  • In the last 5 years, Acadia Pharmaceuticals' Asset Utilization Ratio surged by 3227.01% in 2022 and then tumbled by 1664.39% in 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.68 in 2021, then grew by 27.25% to 0.87 in 2022, then grew by 21.01% to 1.05 in 2023, then dropped by 15.85% to 0.88 in 2024, then decreased by 7.43% to 0.82 in 2025.
  • Its Asset Utilization Ratio stands at 0.82 for Q3 2025, versus 0.86 for Q2 2025 and 0.86 for Q1 2025.